Top Markets
Coin of the day
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Classifica tra le azioni #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Prezzo delle azioni
$0.08765138
Ultima sincronizzazione: 2025-12-23
Capitalizzazione di mercato
$1.11M
Variazione (1 giorno)
0.45%
Variazione (1 anno)
-28.78%
Paese
CA
Scambia Psyence Group Inc. (PSYG)

Categoria

Storico del rendimento da dividendi per Psyence Group Inc. (PSYG)
Il rendimento da dividendi (TTM) di Psyence Group Inc. (simbolo azionario: PSYG) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Psyence Group Inc. (PSYG) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.56%
US
2.04%
US
2.72%
US
2.69%
CH
2.58%
US